A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor. - NCT00796445-53215 (Clinical Trial 254434)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy254434.aspx
|
** Please review additional "Nearby Studies" on right ----->
This is an archived study that is no longer available, if you
would like to find active studies please
search our studies.
|
|
 |
 |
|
| City: |
|
Milwaukee |
|
State:
|
|
WI |
| Zip Code: |
|
53215 |
| Conditions: |
|
Resected Stage III Melanoma With Macroscopic Involvement |
| Purpose: |
|
The purpose of this clinical trial is to evaluate the benefit of the immunotherapeutic
product GSK 2132231A in preventing disease relapse when given to melanoma patients, after
surgical removal of their tumor.
|
| Study summary: |
|
"http://www.immunotherapyforcancer.info provides information on the cancer immunotherapeutic
approach in an easy-to-understand format" "http://www.ascitrials.com gives practical
information on the MAGRIT clinical study" |
| Criteria: |
|
Inclusion Criteria:
- Written informed consent signed.
- Male or female patient with histologically proven stage IIIB or IIIC cutaneous
melanoma presenting with macroscopic lymph node involvement suitable for surgery.
- The patient must have been surgically rendered free of disease before the
randomization.
- Patient is ≥ 18 years old at the time of signing the informed consent form.
- The patient's lymph node tumor shows expression of the MAGE-A3 gene.
- The patient has fully recovered from surgery.
- ECOG performance status of 0 or 1 at the time of randomization.
- The patient must have adequate organ functions as assessed by standard laboratory
criteria.
- If the patient is female, she must be of non-childbearing potential, or practice
adequate contraception.
- In the opinion of the investigator, the patient can and will comply with all the
requirements of the protocol.
Exclusion Criteria:
- The patient suffers from melanoma of non-cutaneous origin.
- The patient has been treated or is scheduled to be treated with an adjuvant
anticancer therapy after the surgery that qualifies the patient for inclusion in the
present trial.
- The patient requires concomitant chronic treatment with systemic corticosteroids or
any other immunosuppressive agents.
- Use of any investigational or non-registered product (drug or vaccine) other than the
study treatment.
- The patient has a history of autoimmune disease.
- The patient has a family history of congenital or hereditary immunodeficiency.
- The patient is known to be positive for Human Immunodeficiency Virus (HIV) or has
another confirmed or suspected immunosuppressive or immunodeficient condition.
- History of allergic disease or reactions likely to be exacerbated by any component of
the treatments.
- The patient has psychiatric or addictive disorders that may compromise his/her
ability to give informed consent or to comply with the trial procedures.
- The patient has concurrent severe medical problems, unrelated to the malignancy, that
would significantly limit full compliance with the study or expose the patient to
unacceptable risk.
- The patient has previous or concomitant malignancies at other sites, except
effectively treated non-melanoma skin cancers or carcinoma in situ of the cervix or
effectively treated malignancy that has been in remission for over 5 years and is
highly likely to have been cured.
- The patient has an uncontrolled bleeding disorder.
- For female patients: the patient is pregnant or lactating. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 4, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|